Haemonetics 3rd Quarter Fiscal Year 2021 Earnings Release Available on Investor Relations Website

Go back to Haemonetics 3rd Quarter Fiscal Year 2021 Earnings Release Available on Investor Relations Website

Haemonetics (HAE) Tops Q3 EPS by 15c, Revenues Beat

February 2, 2021 6:09 AM EST

Haemonetics (NYSE: HAE) reported Q3 EPS of $0.81, $0.15 better than the analyst estimate of $0.66. Revenue for the quarter came in at $240 million versus the consensus estimate of $225.73 million.

Link to 4Q Earnings Guidance

For earnings history and earnings-related data on Haemonetics (HAE) click here.

... More